Total Payments
$1,941
2024 Payments
$686.13
Companies
24
Transactions
81
Medicare Patients
2,234
Medicare Billing
$646,717
Payment Breakdown by Category
Food & Beverage$1,851 (95.4%)
Education$89.99 (4.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,851 | 80 | 95.4% |
| Education | $89.99 | 1 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $541.57 | 24 | $0 (2024) |
| CSL Behring | $227.62 | 8 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $115.65 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $112.13 | 7 | $0 (2022) |
| ABBVIE INC. | $99.69 | 4 | $0 (2024) |
| Allergan Inc. | $97.80 | 6 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $78.82 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $67.31 | 3 | $0 (2017) |
| Ambu Inc. | $62.96 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $61.37 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $686.13 | 24 | CSL Behring ($131.06) |
| 2023 | $249.83 | 10 | CSL Behring ($96.56) |
| 2022 | $144.36 | 6 | Merck Sharp & Dohme LLC ($40.28) |
| 2021 | $60.59 | 3 | Janssen Pharmaceuticals, Inc ($31.24) |
| 2020 | $23.42 | 1 | Advanced Respiratory, Inc ($23.42) |
| 2019 | $86.82 | 5 | PFIZER INC. ($37.87) |
| 2018 | $382.55 | 17 | PFIZER INC. ($261.49) |
| 2017 | $307.66 | 15 | PFIZER INC. ($154.93) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 2 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/01/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $18.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2023 | 3B Medical, Inc. | LUNA (Device) | Food and Beverage | Cash or cash equivalent | $20.67 | General |
| Category: VENTILATOR, NON-CONTINUOUS (RESPIRATOR) | ||||||
| 09/30/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 06/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV | Food and Beverage | In-kind items and services | $30.70 | General |
| 06/09/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/19/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 03/09/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 11/10/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $28.85 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/04/2022 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: EXALT_ENDO | ||||||
| 02/16/2022 | Vapotherm Inc | VAPOTHERM (Device) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/19/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/09/2021 | Fisher & Paykel Healthcare Inc | PT101US/Airvo 2 (Device), OPT944/Optiflow Nasal Cannula, OPT1044/Optiflow 3S Nasal Cannula | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Nasal High Flow | ||||||
| 07/30/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/05/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/03/2020 | Advanced Respiratory, Inc | Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Airway Clearance Device | ||||||
| 10/22/2019 | Vapotherm Inc | Precision Flow (Device) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Respiratory | ||||||
| 10/21/2019 | Vapotherm Inc | Precision Flow (Device) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Respiratory | ||||||
| 05/16/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/25/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/18/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 496 | 1,771 | $540,587 | $173,732 |
| 2022 | 9 | 518 | 1,597 | $401,630 | $133,510 |
| 2021 | 9 | 597 | 1,897 | $427,099 | $172,236 |
| 2020 | 9 | 623 | 1,867 | $418,555 | $167,239 |
Total Patients
2,234
Total Services
7,132
Medicare Billing
$646,717
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 99 | 735 | $220,500 | $71,266 | 32.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 112 | 500 | $171,070 | $54,315 | 31.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 98 | 337 | $74,260 | $24,348 | 32.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 69 | $34,810 | $10,919 | 31.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 70 | 71 | $26,897 | $8,491 | 31.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 38 | 38 | $8,740 | $2,757 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 21 | $4,310 | $1,636 | 38.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 98 | 616 | $160,160 | $52,760 | 32.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 154 | 522 | $104,400 | $35,025 | 33.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 62 | 238 | $69,020 | $22,864 | 33.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 107 | 110 | $33,000 | $10,793 | 32.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 36 | $14,040 | $4,676 | 33.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 20 | $11,400 | $3,783 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 26 | $5,020 | $2,098 | 41.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 14 | 14 | $2,940 | $950.29 | 32.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 15 | $1,650 | $560.93 | 34.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 76 | 670 | $144,484 | $58,029 | 40.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 97 | 363 | $87,846 | $35,533 | 40.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 123 | 495 | $83,655 | $33,785 | 40.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 147 | 156 | $49,764 | $20,244 | 40.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 90 | 91 | $42,952 | $17,023 | 39.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 18 | 66 | $6,006 | $2,395 | 39.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 18 | $4,590 | $1,809 | 39.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 18 | 18 | $4,302 | $1,781 | 41.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 20 | $3,500 | $1,638 | 46.8% |
About Dr. Kabu Chawla, MD
Dr. Kabu Chawla, MD is a Critical Care Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912010018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kabu Chawla, MD has received a total of $1,941 in payments from pharmaceutical and medical device companies, with $686.13 received in 2024. These payments were reported across 81 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,851).
As a Medicare-enrolled provider, Chawla has provided services to 2,234 Medicare beneficiaries, totaling 7,132 services with total Medicare billing of $646,717. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Brooklyn, NY
- Active Since 08/16/2006
- Last Updated 09/11/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912010018
Products in Payments
- ELIQUIS (Drug) $443.37
- Kcentra (Biological) $227.62
- AVYCAZ (Drug) $172.30
- CHANTIX (Drug) $98.20
- OPSUMIT (Drug) $89.99
- DIFICID (Drug) $73.45
- Ambisome (Drug) $67.31
- TRELEGY ELLIPTA (Drug) $61.37
- Arikayce (Drug) $48.95
- XARELTO (Drug) $46.62
- System One (Device) $45.00
- FISHER & PAYKEL HEALTHCARE (Device) $41.10
- ZERBAXA (Drug) $38.68
- EXALT Model D (Device) $34.37
- DUPIXENT (Biological) $33.03
- Precision Flow (Device) $30.51
- LifeVest (Device) $28.85
- UPTRAVI (Drug) $25.66
- VAPOTHERM (Device) $25.48
- TEFLARO (Drug) $25.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Brooklyn
Dr. Joshua Rosenberg, M.d, M.D
Critical Care Medicine — Payments: $893,165
Critical Care Medicine $893,165
Dr. Aaliya Burza, M.d, M.D
Critical Care Medicine — Payments: $54,441
Critical Care Medicine $54,441
Dr. Keerthana Keshava, M.b.b.s, M.B.B.S
Critical Care Medicine — Payments: $23,722
Critical Care Medicine $23,722
Dr. Yizhak Kupfer, Md, MD
Critical Care Medicine — Payments: $22,120
Critical Care Medicine $22,120
Mediha Ibrahim, M.d, M.D
Critical Care Medicine — Payments: $14,961
Critical Care Medicine $14,961
Igor Chernyavskiy, M.d, M.D
Critical Care Medicine — Payments: $7,598
Critical Care Medicine $7,598